Company Filing History:
Years Active: 2006-2012
Title: Jamie Talisman: Innovator in Pharmaceutical Composition
Introduction
Jamie Talisman is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental health conditions. With a total of 4 patents to her name, Talisman is recognized for her innovative approaches to drug development.
Latest Patents
One of Jamie Talisman's latest patents focuses on the use of GALR3 receptor antagonists for the treatment of depression and/or anxiety. This invention is directed to indolone derivatives that act as antagonists for the GALR3 receptor. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of a compound and a pharmaceutically acceptable carrier. Additionally, the invention provides a process for creating this pharmaceutical composition, ensuring that it is both effective and safe for therapeutic use.
Career Highlights
Jamie Talisman is currently employed at H. Lundbeck A/S, a company known for its dedication to improving the quality of life for people suffering from brain diseases. Her work at Lundbeck has allowed her to focus on developing innovative treatments that address critical mental health issues.
Collaborations
Throughout her career, Talisman has collaborated with notable colleagues, including Michael J. Konkel and John M. Werzel. These partnerships have contributed to her success and the advancement of her research in the pharmaceutical field.
Conclusion
Jamie Talisman is a trailblazer in the pharmaceutical industry, with a focus on developing innovative treatments for mental health conditions. Her contributions through her patents and collaborations highlight her commitment to improving patient outcomes.